R2 Technology has introduced at the RSNA meeting its new dual-mode ImageChecker, a single computer-aided detection unit that can process analog and digital mammography images simultaneously.
R2 Technology has introduced at the RSNA meeting its new dual-mode ImageChecker, a single computer-aided detection unit that can process analog and digital mammography images simultaneously.
The company also features at its booth standard mammography software that allows radiologists to compare last year's analog images with this year's digital ones. The software, obtained through an exclusive arrangement with Mirada, processes both types of images with the same set of software tools.
"By introducing software capability that takes two different renderings, two different analog and digital exposure parameters, and normalizes them to look like one another, we're trying to accelerate and embrace the movement toward digital and help individual facilities make the transition from analog to digital technology," said R2 CEO Mike Klein.
The software takes previously acquired analog images, which may appear grainy and fuzzy, and makes them look as if they had been captured using the latest digital acquisition format by smoothing out the borders of the breast, examining the physical properties of the breast, and taking a statistical sampling of the density of the breast.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Mammography Study: AI Facilitates Greater Accuracy and Longer Fixation Time on Suspicious Areas
July 8th 2025While noting no differences in sensitivity, specificity or reading time with adjunctive AI for mammography screening, the authors of a new study noted a 4 percent higher AUC and increased fixation time on lesion regions.
Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?
June 17th 2025While the addition of contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) led to over a 13 percent increase in false positive cases, researchers also noted over double the cancer yield per 1,000 women in comparison to DBT alone.
Contrast-Enhanced Mammography and High-Concentration ICM Dosing: What a New Study Reveals
June 16th 2025New research showed a 96 to 97 percent sensitivity for contrast-enhanced mammography (CEM) with an increased iodine delivery rate facilitating robust contrast enhancement for women with aggressive breast cancer.